Search research articles
Contact Us
Filters
Showing results (211-220 of 219) with videos related to
Page
of 22
Sort By:
You have reached the last page of results.
This site can display upto 219 results.
Therapeutic Advances in Ophthalmology
|
August 21, 2025
Plain language summary of publication of the 48-week results from the PULSAR study investigating how well a new dose of aflibercept works and how safe it is for people with wet age-related macular degeneration
Paolo Lanzetta, Jean-François Korobelnik, Jeffrey S Heier, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 31, 2018
<i>CFH</i> and <i>VIPR2</i> as susceptibility loci in choroidal thickness and pachychoroid disease central serous chorioretinopathy
Yoshikatsu Hosoda, Munemitsu Yoshikawa, Masahiro Miyake, et al.
Lancet (London, England)
|
March 10, 2024
Intravitreal aflibercept 8 mg in neovascular age-related macular degeneration (PULSAR): 48-week results from a randomised, double-masked, non-inferiority, phase 3 trial
Paolo Lanzetta, Jean-François Korobelnik, Jeffrey S Heier, et al.
Ophthalmology
|
August 28, 2025
Intravitreal Aflibercept 8 mg in Neovascular Age-related Macular Degeneration: 96-Week Results from the Randomized Phase 3 PULSAR Trial
Jean-François Korobelnik, Paolo Lanzetta, Sergio Leal, et al.
Ophthalmology and Therapy
|
March 28, 2026
Six-Year Outcomes in Subjects with Polypoidal Choroidal Vasculopathy in the PLANET Study
Kelvin Yi Chong Teo, Young Hee Yoon, Shigeru Honda, et al.
Retina (Philadelphia, Pa.)
|
November 28, 2023
INCIDENCE AND RISK FACTORS OF INTRAOCULAR INFLAMMATION AFTER BROLUCIZUMAB TREATMENT IN JAPAN: A Multicenter Age-Related Macular Degeneration Study
Satoru Inoda, Hidenori Takahashi, Maiko Maruyama-Inoue, et al.
Communications Biology
|
December 25, 2019
Genome-wide association analyses identify two susceptibility loci for pachychoroid disease central serous chorioretinopathy
Yoshikatsu Hosoda, Masahiro Miyake, Rosa L Schellevis, et al.
Scientific Reports
|
August 25, 2017
A prospective multicenter study on genome wide associations to ranibizumab treatment outcome for age-related macular degeneration
Kenji Yamashiro, Keisuke Mori, Shigeru Honda, et al.
Nature Communications
|
January 29, 2015
New loci and coding variants confer risk for age-related macular degeneration in East Asians
Ching-Yu Cheng, Kenji Yamashiro, Li Jia Chen, et al.
Page
of 22
Search research articles
Search
Showing results (211-220 of 219) with videos related to
Sort By:
Page
of 22
You have reached the last page of results.
This site can display upto 219 results.
Therapeutic Advances in Ophthalmology
|
August 21, 2025
Plain language summary of publication of the 48-week results from the PULSAR study investigating how well a new dose of aflibercept works and how safe it is for people with wet age-related macular degeneration
Paolo Lanzetta, Jean-François Korobelnik, Jeffrey S Heier, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 31, 2018
<i>CFH</i> and <i>VIPR2</i> as susceptibility loci in choroidal thickness and pachychoroid disease central serous chorioretinopathy
Yoshikatsu Hosoda, Munemitsu Yoshikawa, Masahiro Miyake, et al.
Lancet (London, England)
|
March 10, 2024
Intravitreal aflibercept 8 mg in neovascular age-related macular degeneration (PULSAR): 48-week results from a randomised, double-masked, non-inferiority, phase 3 trial
Paolo Lanzetta, Jean-François Korobelnik, Jeffrey S Heier, et al.
Ophthalmology
|
August 28, 2025
Intravitreal Aflibercept 8 mg in Neovascular Age-related Macular Degeneration: 96-Week Results from the Randomized Phase 3 PULSAR Trial
Jean-François Korobelnik, Paolo Lanzetta, Sergio Leal, et al.
Ophthalmology and Therapy
|
March 28, 2026
Six-Year Outcomes in Subjects with Polypoidal Choroidal Vasculopathy in the PLANET Study
Kelvin Yi Chong Teo, Young Hee Yoon, Shigeru Honda, et al.
Retina (Philadelphia, Pa.)
|
November 28, 2023
INCIDENCE AND RISK FACTORS OF INTRAOCULAR INFLAMMATION AFTER BROLUCIZUMAB TREATMENT IN JAPAN: A Multicenter Age-Related Macular Degeneration Study
Satoru Inoda, Hidenori Takahashi, Maiko Maruyama-Inoue, et al.
Communications Biology
|
December 25, 2019
Genome-wide association analyses identify two susceptibility loci for pachychoroid disease central serous chorioretinopathy
Yoshikatsu Hosoda, Masahiro Miyake, Rosa L Schellevis, et al.
Scientific Reports
|
August 25, 2017
A prospective multicenter study on genome wide associations to ranibizumab treatment outcome for age-related macular degeneration
Kenji Yamashiro, Keisuke Mori, Shigeru Honda, et al.
Nature Communications
|
January 29, 2015
New loci and coding variants confer risk for age-related macular degeneration in East Asians
Ching-Yu Cheng, Kenji Yamashiro, Li Jia Chen, et al.
Page
of 22